Medtronic (MDT) Tops Q2 EPS by 2c; Guides FY23 EPS Below the Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips below $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
Medtronic dips on miss and lower guidance from slow procedure and supply recovery
November 22, 2022 9:01 AM ESTMedtronic (NYSE: MDT) fell nearly 5% in pre-open trading Tuesday following a miss on the top-line for the second quarter and lower full-year guidance.
The medical device maker reported that revenue fell 3% to $7.6 billion, missing the Wall Street consensus of $7.7 billion. The company said the results reflect "slower supply recovery or lower than anticipated underlying market procedure volumes in certain businesses and... More
